Influence of n-3 fatty acid supplementation on the endogenous activities of plasma lipases

American Journal of Clinical Nutrition

Volumn 66, Issue 2, 1997, Pages 254-260

  Harris, William S ^a   Lu, Gouping ^b   Rambjør, Gro S ^b   Wålen, Ann I ^b   Ontko, Joseph A ^b   Cheng, Q ^b   Windsor, S L ^b  

^a ST LUKE S HOSPITAL   (United States)

^b NONE

Author keywords

Docosahexaenoic acid; Eicosapentaenoic acid; Hepatic lipase; Humans; Lipoprotein lipase; N 3 fatty acids; Plasma phospholipid fatty acids

Indexed keywords

ALPHA TOCOPHEROL; ARACHIDONIC ACID; CHOLESTEROL; DOCOSAHEXAENOIC ACID; FISH OIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; LINOLEIC ACID; LIPOPROTEIN LIPASE; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OLEIC ACID; OLIVE OIL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; ENZYME ACTIVITY; HUMAN; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; LIPOLYSIS; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TRIACYLGLYCEROL BLOOD LEVEL; TRIACYLGLYCEROL LIPASE BLOOD LEVEL;

EID: 0030790270     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/66.2.254     Document Type: Article

References (55)

1. Harris WS, Connor WE, McMurry MP. The comparative reductions of the plasma lipids and lipoproteins by dietary polyunsaturated fats: salmon oil versus vegetable oils. Metabolism 1983;32:179-84.
2. Phillipson BE, Rothrock DW, Connor WE, Harris WS, Illingworth DR. Reduction of plasma lipids, lipoproteins and apoproteins by dietary fish oils in patients with hypertriglyceridemia. N Engl J Med 1985;312:1210-6.
3. Harris WS. Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review. J Lipid Res 1989;30:785-807.
4. Harris WS. n-3 fatty acids and lipoproteins: comparison of results from human and animal studies. Lipids 1996;31:243-52.
5. Harris WS, Connor WE, Illingworth DR, Rothrock DW, Foster DM. Effects of fish oil on VLDL triglyceride kinetics in humans. J Lipid Res 1990;31:1549-58.
6. Sanders TAB, Sullivan DR, Reeve J, Thompson GR. Triglyceride-lowering effect of marine polyunsaturates in patients with hypertriglyceridemia. Arteriosclerosis 1985;5:459-65.
7. Harris WS, Connor WE, Alam N, Illingworth DR. Reduction of postprandial triglyceridemia in humans by dietary omega-3 fatty acids. J Lipid Res 1988;29:1451-60.
8. Weintraub MS, Zechner R, Brown A, Eisenberg S, Breslow JL. Dietary polyunsaturated fats of the ω-6 and ω-3 series reduce postprandial lipoprotein levels. J Clin Invest 1988;82:1884-93.
9. Nozaki S, Garg A, Vega GL, Grundy SM. Postheparin lipolytic activity and plasma lipoprotein response to ω-3 polyunsaturated fatty acids in patients with primary hypertriglyceridemia. Am J Clin Nutr 1991;53:638-42.
10. Glaser DS, Yost TJ, Eckel RH. Preheparin lipoprotein lipase activities: relationship to plasma lipoproteins and postheparin lipolytic activities. J Lipid Res 1992;33:209-14.
11. Harris WS, Hustvedt BE, Hagen E, Green MH, Lu GP, Drevon CA. n-3 Fatty acids in chylomicron metabolism in the rat. J Lipid Res 1997;138:503-15.
12. Sztern MI, Harris WS. Short-term effects of fish oil on human plasma lipid levels. J Nutr Biochem 1991;2:255-9.
13. Harris WS, Muzio F. Fish oil reduces postprandial triglyceride concentrations without accelerating lipid-emulsion removal rates. Am J Clin Nutr 1993;58:68-74.
14. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;19:499-502.
15. Gidez LI, Miller GJ, Burnstein M, Slagle S, Eder HA. Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. J Lipid Res 1982;23:1206-23.
16. Wang CS, Bass HB, Downs D, Whitmer RK. Modified heparin sepharose procedure for determination of plasma lipolytic activities of normolipidemic and hyperlipidemic subjects after injection of heparin. Clin Chem 1981;25:663-8.
17. Boberg J, Augustin J, Baginsky ML, Tejada P, Brown WV. Quantitative determination of hepatic and lipoprotein lipase activities from human postheparin plasma. J Lipid Res 1977;18:544-7.
18. Eckel RH, Goldberg IJ, Steiner L, Yost TJ, Paterniti JR Jr. Plasma lipolytic activity: relationship to postheparin lipolytic activity and evidence for metabolic regulation. Diabetes 1988;37:610-5.
19. Nilsson-Ehle P, Schotz MC. A stable, radioactive substrate emulsion for assay of lipoprotein lipase. J Lipid Res 1976;17:536-41.
20. Karpe F, Olivecrona T, Walldius G, Hamsten A. Lipoprotein lipase in plasma after an oral fat load: relation to free fatty acids. J Lipid Res 1992;33:975-84.
21. Watson TDG, Tan CE, McConnell M, Clegg SK, Squires LF, Packard CJ. Measurement and physiological significance of lipoprotein and hepatic lipase activities in preheparin plasma. Clin Chem 1995;41:405-12.
22. Hahn P. Abolishment of alimentary lipemia following injection of heparin. Science 1943;98:19-20.
23. Korn ED. Properties of clearing factor obtained from rat heart acetone powder. Science 1954;120:399-400.
24. Engelberg H. Human endogenous clearing factor (active factor). Am J Physiol 1955;181:309-12.
25. Tornvall P, Olivecrona G, Karpe F, Hamsten A, Olivecrona T. Lipoprotein lipase mass and activity in plasma and their increase after heparin are separate parameters with different relations to plasma lipoproteins. Arterioscler Thromb Vasc Biol 1995;15:1086-93.
26. Cheng Q, Blackett PR, Wang CS, Fesmire JD, Corder CN. Use of plasma lipoprotein lipase activity without heparin injection for detection of homozygous and heterozygous lipoprotein lipase deficiency. Ann N Y Acad Sci 1991;623:410-2.
27. Vilella E, Joven J, Fernandez M, et al. Lipoprotein lipase in human plasma is mainly inactive and associated with cholesterol-rich lipoproteins. J Lipid Res 1993;34:1555-64.
28. Goldberg IJ, Kandel JJ, Blum CB, Ginsberg HN. Association of plasma lipoproteins with postheparin lipase activities. J Clin Invest 1986;78:1523-8.
29. Beisiegel U, Weber W, Bengtsson-Olivecrona G. Lipoprotein lipase enhances the binding of chylomicrons to the low density lipoprotein receptor-related protein. Proc Natl Acad Sci U S A 1991;88:8342-6.
30. Rumsey SC, Obunike JC, Arad Y, Deckelbaum RJ, Goldberg IJ. Lipoprotein lipase-mediated uptake and degradation of low density lipoproteins by fibroblasts and macrophages. J Clin Invest 1992;90:1504-12.
31. 2-macroglobulin receptor is induced by the C-terminal domain of lipoprotein lipase. J Biol Chem 1994;269:18001-6.
32. Nykjaer A, Nielsen M, Lookene A, et al. A carboxyl-terminal fragment of lipoprotein lipase binds to the low density lipoprotein receptor-related protein and inhibits lipase-mediated uptake of lipoprotein in cells. J Biol Chem 1994;269:31747-55.
33. Eisenberg S, Sehayek E, Olivecrona T, Vlodavsky I. Lipoprotein lipase enhances binding of lipoproteins to heparan sulfate on cell surfaces and extracellular matrix. J Clin Invest 1992;90:2013-21.
34. Obunike JC, Edwards IJ, Rumsey SC, et al. Cellular differences in lipoprotein lipase-mediated uptake of low density lipoproteins. J Biol Chem 1994;269:13129-35.
35. Demant T, Carlson LA, Holmquist L, et al. Lipoprotein metabolism in hepatic lipase deficiency: studies on the turnover of apoB and on the effect of HL on HDL. J Lipid Res 1988;29:1603-11.
36. Olsson AG, Carlson LA, Carlson K. Conversion of the electrophoretic pattern of type IV hyperlipidaemia to type III by intravenous heparin. Acta Med Scand 1978;203:487-90.
37. Goldberg IJ, Le NA, Ginsberg HN, Krauss RM, Lindgren FT. Lipoprotein metabolism during acute inhibition of lipoprotein lipase in the cynomolgus monkey. J Clin Invest 1988;81:561-8.
38. Goldberg IJ, Le NA, Paterniti JR Jr, Ginsberg HN, Lindgren FT, Brown WV. Lipoprotein metabolism during acute inhibition of hepatic triglyceride lipase in the cynomolgus monkey. J Clin Invest 1982;70:1184-92.
39. Stalenhoef AFH, Malloy MJ, Kane JP, Havel RJ. Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in normal and lipoprotein lipase-deficient humans. Proc Natl Acad Sci U S A 1984;81:1839-43.
40. Leaf DA, Connor WE, Illingworth DR, Bacon SP, Sexton G. The hypolipidemic effects of gemfibrozil in type V hyperlipidemia. J Am Med Assoc 1989;262:3154-60.
41. Grundy SM, Vega GL. Fibric acids: effects on lipids and lipoprotein metabolism. Am J Med 1987;83:9-20.
42. Dallongeville J, Boulet L, Davignon J, Lussier-Cacan S. Fish oil supplementation reduces β-very low density lipoprotein in type III dysbetalipoproteinemia. Arterioscler Thromb 1991;11:864-71.
43. Saxena U, Goldberg IJ. Interaction of lipoprotein lipase with glycosaminoglycans and apolipoprotein C-II: effects of free-fatty-acids. Biochim Biophys Acta 1990;1043:161-8.
44. Herzberg GR. Dietary regulation of fatty acid and triglyceride metabolism. Can J Physiol Pharmacol 1991;69:1637-47.
45. Kasim-Karakas SE, Herrmann R, Almario R. Effects of omega-3 fatty acids on intravascular lipolysis of very-low-density lipoproteins in humans. Metabolism 1995;44:1223-30.
46. Haug A, Hostmark AT. Lipoprotein lipases, lipoproteins and tissue lipids in rats fed fish oil or coconut oil. J Nutr 1987;117:1011-7.
47. Groot PHE, Scheek LM, Dubelaar ML, Verdouw PD, Hartog JM, Lamers JMJ. Effects of diets supplemented with lard fat or mackerel oil on plasma lipoprotein lipid concentrations and lipoprotein lipase activities in domestic swine. Atherosclerosis 1989;77:1-6.
48. Huff MW, Telfoid DE, Edmonds BW, McDonald CG, Evans AJ. Lipoprotein lipases, lipoprotein density gradient profile and LDL receptor activity in miniature pigs fed fish oil and corn oil. Biochim Biophys Acta 1993;1210:113-22.
49. Mizuguchi K, Yano T, Ishibashi M, Masada A, Mizota M, Sato Y. Ethyl all-cis-5,8,11,14,17-icosapentaenoate modifies the biochemical properties of rat very low-density lipoprotein. Eur J Pharmacol 1993;235:221-7.
50. Nestel PJ, Connor WE, Reardon MR, Connor SL, Wong S, Boston R. Suppression by diets rich in fish oil of very low density lipoprotein production in man. J Clin Invest 1984;74:72-89.
51. Huff MW, Telford DE. Dietary fish oil increases conversion of very low density lipoprotein apoprotein B to low density lipoprotein. Arteriosclerosis 1989;9:58-66.
52. Greten H, Laible V, Zipperle G, Augustin J. Comparison of assay methods for selective measurement of plasma lipase. Atherosclerosis 1977;26:563-72.
53. Abbey M, Clifton P, Kestin M, Belling B, Nestel P. Effect of fish oil on lipoproteins, lecithin:cholesterol acyltransferase, and lipid transfer protein activity in humans. Arteriosclerosis 1990;10:85-94.
54. Harris WS, Windsor SL, Caspermeyer JJ. Modification of lipid-related atherosclerosis risk factors by ω3 fatty acid ethyl esters in hypertriglyceridemic patients. J Nutr Biochem 1993;4:706-12.
55. Franceschini G, Calabresi L, Maderna P, Galli C, Gianfranceschi G, Sirtori CR. ω-3 Fatty acids selectively raise high-density lipoprotein 2 levels in healthy volunteers. Metabolism 1991;40:1283-6.